Hillcrest Energy Technologies Announces Strategic Venture with Pasqua First Nation #79 and Apeiron Resources Ltd. and Private Placement

The most recent news, dated October 14, 2025, from Hillcrest Energy Technologies announces a multi-faceted update:

1. Strategic Venture: A Memorandum of Understanding (MOU) with Pasqua First Nation #79 (PFN) and a Letter Agreement with Apeiron Resources Ltd. to establish an Indigenous-majority owned entity (NEWCO) in Canada. NEWCO is intended to commercialize Hillcrest's Zero Voltage Switching (ZVS) power conversion technology, with PFN owning 51% and Hillcrest/Apeiron collectively 49%. Hillcrest would be compensated for technology development. PFN may invest up to $3 million in Hillcrest, and NEWCO aims to raise over $10 million through government grants, loans, and other investments. Both agreements are explicitly described as non-binding frameworks.
2. Private Placement Offering: A proposed non-brokered private placement of units for up to $7.2 million.
   • Cash Offering: Up to $3.9 million at $0.09 per unit. Proceeds for technology development, marketing, investor relations, retirement of existing accounts payable, and general working capital. A portion is linked to the potential PFN investment.
   • Debt Offering/Settlement: Up to $3.3 million to settle approximately $1.32 million in loans, $1.7 million in debentures (issued January 29, 2025, and March 4, 2025), and $280,000 in outstanding service invoices and director fees. Units are issued at a deemed price of $0.09.
   • Unit Composition: Each unit consists of one common share and one common share purchase warrant.
   • New Warrants: Each new warrant is exercisable at $0.12 per common share for 24 months, with an acceleration clause if the stock trades at $0.36 VWAP for 10 consecutive days.
   • Insider Participation: Directors are expected to settle approximately $65,800 in fees via ~731,111 units, qualifying as an exempt related party transaction.
3. Cancellation of Previous Private Placement: A non-brokered private placement previously announced on March 11, 2025, has been cancelled. Discussions with the associated strategic investor are ongoing.
4. Warrant Extension Confirmation: The extension of 4.35 million warrants (original exercise price $0.50, original expiry October 4, 2025) to October 4, 2027, has been confirmed with all warrant holders. This follows a proposal announced on September 26, 2025.

The October 14, 2025, news presents a mixed, but predominantly negative, material impact when viewed critically and in the context of the company's prior news.

Positive Aspects (Superficial): * Addressing Capital Needs: The private placement aims to bring in up to $3.9 million in cash and settle $3.3 million in existing debt. This provides some immediate relief from pressing financial obligations and injects capital for operations.

Negative Aspects (Substantial): * Highly Dilutive Financing: The $0.09 per unit offering price is extremely low, representing a significant discount to historical highs and even recent trading levels (the 52-week high was $0.47, and the price on the last trading day was $0.10). This will result in substantial dilution for existing shareholders, as a large number of new shares will be issued. The conversion of a significant amount of debt (~$3.3 million) into equity at such a low price is a clear sign of financial distress and an inability to meet obligations in cash. * Cancellation of Previous Financing: The cancellation of the private placement announced in March 2025 is a major red flag. It indicates a failure to secure anticipated funding, suggesting difficulties in attracting investors and executing financing plans. While discussions are "ongoing," the cancellation signals a setback. * Non-Binding Strategic Venture: The "strategic partnership" with PFN and Apeiron is presented as an MOU and Letter Agreement, explicitly stated as "non-binding frameworks for cooperation." This means there is no firm commitment for the NEWCO to be established, nor for the $10+ million in funding to be secured, or even for the PFN's potential $3 million investment in Hillcrest to materialize. Hillcrest's compensation terms for technology licensing are also "to be agreed." As such, this appears to be more of an aspirational announcement than a concrete step towards commercialization or significant funding. Investors should be highly skeptical of the immediate value of such non-binding agreements. * Warrant Extension Confirmed: The confirmation of the extension of 4.35 million warrants at a $0.50 exercise price to October 2027 is a negative signal. These warrants are deeply out-of-the-money relative to the current share price ($0.10) and even the new private placement price ($0.09). Extending them suggests the company lacks confidence in its ability to significantly increase its share price within the original timeframe to make these warrants attractive for exercise. It represents an attempt to retain existing warrant holders rather than attracting new investment based on strong performance. * Debt Issues: The fact that nearly half of the proposed private placement is dedicated to settling existing debt and accounts payable ($3.3 million out of $7.2 million total offering size) underscores the company's precarious debt situation and short-term capital needs. This is not growth capital but rather survival capital. * Insufficient Detail on Share Structure: Without the current outstanding share count, it's impossible to fully quantify the dilutive impact of this offering or calculate a precise market capitalization. However, the number of units proposed for issuance (up to 80 million units if fully subscribed) is likely a significant percentage of the existing float, especially for a company trading at sub-$0.10 levels.

In summary, while the company is taking steps to address its immediate capital shortfall, it is doing so at a steep cost to existing shareholders through heavy dilution. The "strategic partnership" lacks concrete commitments, and the cancellation of a previous financing combined with the extension of out-of-the-money warrants paint a picture of a company facing significant financial challenges and struggling to execute its long-term strategy. The overall impact is materially negative due to the high cost of capital and the speculative nature of its growth initiatives.

Hillcrest Energy Technologies is a clean technology company focused on developing and commercializing its Zero Voltage Switching (ZVS) power conversion technology. This technology aims to improve the efficiency and performance of power electronics across various applications, including electric vehicles, grid-connected renewable energy systems, and industrial motors. The flagship project is the development and deployment of this ZVS power conversion technology. The company's strategy involves licensing its technology and establishing partnerships for commercialization.